Intensive Nutrition in Critically Ill Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

February 27, 2023

Study Completion Date

July 31, 2023

Conditions
Critical IllnessCritically Ill
Interventions
DIETARY_SUPPLEMENT

Supplemental parenteral nutrition

Supplemental parenteral nutrition OLIMEL N12E (Baxter Healthcare Corporation)

Trial Locations (23)

1023

Auckland City Hospital CVICU, Auckland

2025

Middlemore Hospital, Auckland

2148

Blacktown Hospital, Blacktown

2747

Nepean Hospital, Kingswood

3004

The Alfred Hospital, Melbourne

3010

Royal Melbourne Hospital, Melbourne

3076

Northern Hospital, Epping

3084

Austin Hospital, Heidelberg

3121

Epworth Richmond, Melbourne

3128

Box Hill Hospital, Melbourne

3168

Monash Medical Centre, Melbourne

3199

Frankston Hospital - Peninsula Health, Frankston

3220

Geelong Hospital, Geelong

3350

Ballarat Hospital, Ballarat

3550

Bendigo Hospital, Bendigo

4020

Redcliffe Hospital, Redcliffe

4032

Prince Charles Hospital, Brisbane

4101

Mater Hospital, South Brisbane

4102

Princess Alexandra Hospital, Woolloongabba

4215

Gold Coast University Hospital, Southport

5011

Queen Elizabeth Hospital, Woodville South

5112

Lyell McEwin, Elizabeth Vale

0810

Royal Darwin Hospital, Darwin

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Australian and New Zealand Intensive Care Research Centre

OTHER

NCT03292237 - Intensive Nutrition in Critically Ill Adults | Biotech Hunter | Biotech Hunter